Janssen Funds New Global Leadership Initiative on Brain Health

TITUSVILLE, N.J., July 12, 2016 /PRNewswire/ — Janssen Research & Development, LLC (“Janssen”), one of the Janssen Pharmaceutical Companies of Johnson & Johnson, announced today new funding for a global initiative to activate leaders from diverse backgrounds to transform society’s approach to mental health. As the founding sponsor of The One Mind Initiative, Janssen has provided $1.1 million in funding with a goal of delivering better health and economic outcomes in brain health. Support for The One Mind Initiative is part of Janssen’s global Healthy Minds program which encourages collaboration to accelerate new solutions for neurologic and brain diseases.With this funding, The One Mind Initiative has been started by The Kennedy Forum and the One Mind Institute, doing business as IMHRO (International Mental Health Research Organization). The One Mind Initiative is designed…


Link to Full Article: Janssen Funds New Global Leadership Initiative on Brain Health